SFX by Ex Libris Inc.

Title:	Adoptive cell transfer as personalized immunotherapy for human cancer
Source:	Science [0036-8075] Rosenberg, S A yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Schumacher, Ton N. "Neoantigens in cancer immunotherapy." Science 348.6230 (2015): 69-74.
description	2.	Rosenberg, Steven A. "Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy." Clinical cancer research 17.13 (2011): 4550-4557.
description	3.	June, Stanley H. "Adoptive cellular therapy: A race to the finish line." Science translational medicine 7.280 (2015): 280-280.
description	4.	Restifo, Nicholas P. "Adoptive immunotherapy for cancer: harnessing the T cell response." Nature reviews. Immunology 12.4 (2012): 269-281.
description	5.	Curran, Kevin J. "Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions." The journal of gene medicine 14.6 (2012): 405-415.
description	6.	Joyce, Johanna A. "T cell exclusion, immune privilege, and the tumor microenvironment." Science 348.6230 (2015): 74-80.
description	7.	Allison, James P. "The future of immune checkpoint therapy." Science 348.6230 (2015): 56-61.
description	8.	Gubin, M. "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens." Nature 515.7528 (2014): 577-81.
description	9.	Klebanoff, Nicholas A. "Prospects for gene-engineered T cell immunotherapy for solid cancers." Nature Medicine 22.1 (2016): 26-36.
description	10.	Pardoll, Drew M. "The blockade of immune checkpoints in cancer immunotherapy." Nature Reviews. Cancer 12.4 (2012): 252-264.
description	11.	Beer, Tomasz M. "RANDOMIZED TRIAL OF AUTOLOGOUS CELLULAR IMMUNOTHERAPY WITH SIPULEUCEL-T IN ANDROGEN DEPENDENT PROSTATE CANCER." Clinical cancer research 17.13 (2011): 4558-4567.
description	12.	Gill, S. "Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies." Immunological reviews 263.1 (2015): 68-89.
description	13.	Palucka, K. "Cancer immunotherapy via dendritic cells." Nature Reviews. Cancer 12.4 (2012): 265-277.
description	14.	Gattinoni L, L. "Adoptive immunotherapy for cancer: building on success." Nature reviews. Immunology 6.5 (2006): 383-393.
description	15.	Simpson, Andrew G. "Cancer/testis antigens, gametogenesis and cancer." Nature reviews. Cancer 5.8 (2005): 615-625.
description	16.	Gilham, David E. "CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe." Trends in molecular medicine 18.7 (2012): 377-384.
description	17.	Dudley, M. "Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens." Journal of clinical oncology 26.32 (2008): 5233-9.
description	18.	Turtle, Cameron J. "Engineered T cells for anti-cancer therapy." Current opinion in immunology 24.5 (2012): 633-639.
description	19.	Rosenberg, S. "Adoptive cell transfer: a clinical path to effective cancer immunotherapy." Nature reviews. Cancer 8.4 (2008): 299-308.
description	20.	Linnemann, C. "High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma." Nature medicine 21.1 (2014): 81-85.